Merck Expects Final European Commission Decision Within Two Months
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
11:40:23 AM UTC
SquawkNews
The EU CHMP recommended expanding ENFLONSIA’s indication to prevent RSV lower respiratory tract disease in children up to 24 months at increased risk through their second RSV season. The European Commission is expected to decide within two months.Material DetailsContext by AI AnalystThis is an earl…